CP7q

CFTR potentiator

Phase of research

Pre-clinical

How it helps

Restore CFTR Function

General information

CP7q is an experimental substance used in studies and not yet available as a human pharmaceutical. It is a hydroxypyrazoline analog synthesized as a candidate CFTR potentiator. In relation to cystic fibrosis, our AIM tool found the data that CP7q can help potentiate G551D-CFTR and F508del-CFTR channels.

Synonyms

Compound 7q

Marketed as

N/A

Dietary sources

N/A

Structure image not available

N/A

Drug-Mutation Relation

Treats

Mutation Number of sources Average impact factor
F508del
1 2.81
Link Tested on Impact factor Notes
Potentiation of ΔF508- and G551D-CFTR-Mediated Cl- Current by Novel Hydroxypyrazolines. human cell cultures 2.81
G551D
1 2.81
Link Tested on Impact factor Notes
Potentiation of ΔF508- and G551D-CFTR-Mediated Cl- Current by Novel Hydroxypyrazolines. human cell cultures 2.81 Better than genistein.

Does not treat

Mutation Number of sources Average impact factor